Azepane → 9-[4-(Hexahydro-1H-azepin-yl)butyl]-2-{[(1S)-1-methylbutyl]oxy}-8-(methyloxy)-9H-purin-6-amine
Reaction equation
C(N[C:6]1[N:14]=[C:13]2[C:9]([N:10]=[C:11]([O:26][CH3:27])[N:12]2[CH2:15][CH2:16][CH2:17][CH2:18][N:19]2[CH2:25][CH2:24][CH2:23][CH2:22][CH2:21][CH2:20]2)=[C:8]([NH2:28])[N:7]=1)CCC.FC(F)(F)C(O)=O.[CH3:36][C@H:37]([O:41]C1NC(N)=C2C(N=1)=NC(OC)=N2)[CH2:38][CH2:39][CH3:40].BrCCCCCl.N1CCCCCC1>>[N:19]1([CH2:18][CH2:17][CH2:16][CH2:15][N:12]2[C:11]([O:26][CH3:27])=[N:10][C:9]3[C:13]2=[N:14][C:6]([O:41][C@@H:37]([CH3:36])[CH2:38][CH2:39][CH3:40])=[N:7][C:8]=3[NH2:28])[CH2:20][CH2:21][CH2:22][CH2:23][CH2:24][CH2:25]1Participants
5
Reactant 4
Product 1
Procedure
Prepared similarly to Intermediate 36 from 2-{[(1S)-1-methylbutyl]oxy}-8-(methyloxy)-1H-purin-6-amine trifluoroacetate, 1-bromo-4-chlorobutane, and hexahydro-1H-azepine but with three sequential MDAPs using Method B followed by Method A (×2).
Sources & evidence
- ORD record
- ord-1d40e68ecbcd4e5c9d5d72be8d03f8f4
- Source dataset
- uspto-grants-2011_11
- Patent number
- US08067426B2
Reaction notes
Loading…